Abstract
Several oncoproteins or tumor suppressor gene products have been indicated to be of value as predictors of the de novo resistance to cytotoxic agents. In this study, we have investigated the role of MDM2 (murine double minutes) overexpression in doxorubicin resistance of breast cancer. Immunocytochemical analysis demonstrated that MDM2-positive tumors, even with p53-negative phenotype, were significantly more resistant to doxorubicin treatment compared to MDM2-negative tumors. An in vitro experimental model using stable mdm2-transfected MCF-7 cells carrying wild-type p53 confirmed that the cells become approximately 3-fold more resistant to doxorubicin as a result of MDM2 overexpression, and the wild-type p53 function, such as the induction of p21Waf1 following DNA damage, was significantly suppressed. MDM2 overexpression is suggested to be a novel marker for predicting lack of response to doxorubicin treatment in breast cancer patients.
References
Jul 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B A GustersonR Reed
Jun 26, 1992·Cell·J MomandA J Levine
Jul 2, 1992·Nature·J D OlinerB Vogelstein
May 1, 1987·Somatic Cell and Molecular Genetics·L Cahilly-SnyderD L George
Oct 1, 1993·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·S M Picksley, D P Lane
Jun 30, 1995·Cell·S LeeJ Griffith
Jun 30, 1995·Cell·J Jayaraman, C Prives
Jun 1, 1995·Nature Genetics·X W WangB G Taffe
Jul 1, 1993·Molecular and Cellular Biology·J ChenA J Levine
Jun 22, 1995·Nature·K MartinT Kouzarides
Jun 22, 1995·Nature·Z X XiaoD M Livingston
Jan 1, 1995·The Journal of Pathology·A MarchettiM Barbareschi
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B QuesnelJ P Peyrat
Nov 4, 1994·Science·S W LoweT Jacks
May 1, 1994·Trends in Biochemical Sciences·M N BoddyK L Borden
Sep 7, 1994·Journal of the National Cancer Institute·P LianesC Cordon-Cardo
Sep 7, 1994·Journal of the National Cancer Institute·T HabuchiO Yoshida
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·G BakalkinK G Wiman
Jul 1, 1993·Genes & Development·X WuA J Levine
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K Roemer, T Friedmann
Jul 1, 1996·Nature Medicine·T AasP E Lønning
Aug 1, 1996·Nature Medicine·I SigalasJ Lunec
Oct 1, 1996·British Journal of Cancer·S KondoG H Barnett
Citations
Mar 16, 2006·Apoptosis : an International Journal on Programmed Cell Death·S MaierG Krupitza
Aug 24, 2000·Molecular Medicine Today·E H ChangK B Bouker
Jan 16, 2010·Molecular Pharmaceutics·Danielle S W BenoitPatrick S Stayton
Feb 17, 2001·Biochemical and Biophysical Research Communications·S SajiS Hayashi
Dec 7, 2007·Cancer Letters·Taek-Keun NamByung-Sik Nah
Sep 25, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Laura SmithLynn Cawkwell
Jan 31, 2004·Annals of the New York Academy of Sciences·Hui WangRuiwen Zhang
Apr 6, 1999·Japanese Journal of Cancer Research : Gann·S SajiY Nozawa
Feb 1, 2006·Expert Opinion on Therapeutic Patents·Jinxia DengNouri Neamati
Mar 22, 2018·BMC Cancer·Toshinori OzakiMeixiang Sang
Mar 18, 2004·British Journal of Cancer·H-J TangJ Lin
Apr 20, 2002·Blood·Lubing GuMuxiang Zhou
Oct 24, 2002·American Journal of Clinical Oncology·Masahide IkeguchiNobuaki Kaibara
Jan 23, 2016·Oncotarget·Shin-Hyung ParkHo-Young Lee
Aug 24, 2019·Cancer Cell International·Helei HouXiaochun Zhang
Dec 18, 2001·British Journal of Cancer·H A CockerL R Kelland
Mar 7, 2020·Science Advances·Ziyu LiJiafu Ji
Nov 10, 2020·Archives of Pharmacal Research·Jinyoung ParkEun Joo Song
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhuo ZhangRuiwen Zhang
Jan 25, 2006·Molecular Cancer Therapeutics·Holly K KoblishAnna C Maroney